AI | pharmaphorum

Wednesday 1 April 2026

AI

Market Access

tech bubble network graphic representation in blue and green tones

BIO Boston: 2025 is shaping up to be a year of challenge – b...

What were the major themes to come out of BIO Boston 2025? Despite global events in the background, a fair amount of positivity.

Market Access

AI as document reviewer

Balancing efficiency with risks: How biopharma companies can...

AI technologies can enable companies to program, rather than write, submissions to health authorities.

Digital

Interview at BIO 2025 Brian Alexander

Asking the right questions around AI, with Brian Alexander, ...

At BIO 2025, editor-in-chief Jonah Comstock spoke with Brian Alexander, CEO of Valo Health, about how he’s seeing the AI conversation evolve.

Digital

Clinical trial enrolment offerings

Beyond AI hype: How dynamic study forecasting is helping pha...

The industry must move beyond hype and address the real-world applications of AI for accurate enrolment forecasting.

Digital

Interview at BIO 2025 with Hanadie Yousef

‘Insulin for muscle’ and the AI platform behind it, with Han...

Digital

lady using laptop device with graphic overlay

Sponsored

One assistant to rule them all? Why the future of work is pl...

How many tools do you usually use at work? One to two, or is it closer to five or six?